Compare AU
Compare JEPI vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are JEPI and DRUG. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
JEPI | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 12 | 63 |
Median incremental investment | $1,243.33 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,276.42 | $1,875.72 |
Average age group | > 35 | 26 - 35 |
Key Summary
JEPI | DRUG | |
|---|---|---|
Strategy | JEPI.AX was created on 2022-11-08 by JPMorgan. The fund's investment portfolio concentrates primarily on extended market equity. The investment objective of the Fund is to seek current0F 1 income while maintaining prospects for capital appreciation. The Fund seeks to provide the majority of the returns associated with the S&P 500 Index while exposing investors to less risk through lower volatility and still offering incremental income. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Jpmorgan Eq Prem Income Active ETF (Managed Fund) (100 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | |
Top 3 countries | United States (97.04 %) Netherlands (2.05 %) Singapore (0.47 %) | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) |
Management fee | 0.4 % | 0.57 % |
Key Summary
JEPI | DRUG | |
|---|---|---|
Issuer | JPMorgan | BetaShares |
Tracking index | S&P 500 - AUD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.4 % | 0.57 % |
Price | $56.49 | $8.12 |
Size | N/A | $191.120 million |
10Y return | N/A | N/A |
Annual dividend/ distribution yield (5Y) | 2.78 % | 1.90 % |
Market | ASX | ASX |
First listed date | 09/11/2022 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
JEPI | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 12 | 63 |
Median incremental investment | $1,243.33 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,276.42 | $1,875.72 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
JEPI | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
JEPI | DRUG |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |